EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Exosomal lncRNA FENDRR Orchestrates Immune Remodelling and Ferroptosis in the Comorbidity of Lung Cancer and Type 1 Myocardial Infarction

Youfu He iD, Yu Qian iD, Zhiwei Zheng iD, Yu Zhou iD, Chen Li iD, Qiang Wu iD, Minghua Ren

Human Mutation · 2026

DOI: 10.1155/humu/8861747 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Mutation, 2026. Verfasst von Youfu He und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Guizhou Provincial People's Hospital, Guiyang City, Guizhou Province, China, 5055.cn. Hauptthemen laut MEDLINE: Exosomes, RNA, Long Noncoding, Lung Neoplasms, Myocardial Infarction. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science and Technology Program of Guizhou Province, Health Commission of Guizhou Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lung cancer and Type 1 myocardial infarction (T1MI) increasingly co‐occur, yet the molecular basis underlying their interaction remains unclear. In this study, we combined multiomics profiling, in vivo and in vitro models and human clinical samples to investigate the regulatory role of the exosomal long noncoding RNA FENDRR in cancer–cardiovascular comorbidity. We found that FENDRR was markedly elevated in thrombus‐derived exosomes from T1MI patients and promoted cardiomyocyte ferroptosis and ferritinophagy through the NCOA4–GPX4–P62 axis, thereby exacerbating myocardial injury. Silencing FENDRR significantly alleviated cardiac damage in the T1MI rat model. In contrast, FENDRR was consistently downregulated across multiple cancers, particularly lung adenocarcinoma (LUAD). Higher FENDRR expression was associated with favourable patient survival, and time‐dependent ROC analysis demonstrated robust prognostic performance in LUAD (5 − year AUC = 0.990). Multiomics and immunogenomic analyses further revealed that FENDRR expression correlated with distinct remodelling of the tumour immune microenvironment, including alterations in immune cell infiltration, immune activation scores, chemokine and HLA gene expression and antigen‐presentation capacity. These findings were supported by single‐cell analyses and by enhanced CD8 + T‐cell and Treg infiltration in thrombi from patients with LUAD and T1MI. Collectively, our results identify FENDRR as a context‐dependent regulator that promotes myocardial injury but may exert tumour‐suppressive and immune‐modulatory functions in lung cancer. These insights provide a mechanistic framework for cancer–cardiovascular comorbidity and highlight FENDRR as a potential biomarker and therapeutic target across disease contexts.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ExosomesRNA, Long NoncodingLung NeoplasmsMyocardial InfarctionFerroptosisHumansAnimalsRatsTumor MicroenvironmentComorbidityGene Expression Regulation, NeoplasticMalePrognosis

Stichwörter der Autor:innen

FENDRRType 1 myocardial infarctionexosomesimmune microenvironmentlung cancer

Substanzen

RNA, Long Noncoding

Autor:innen und Institutionen

  • Department of Cardiology, Guizhou Provincial People's Hospital, Guiyang City, Guizhou Province, China, 5055.cn.
  • Medical College, Guizhou University, Guiyang City, Guizhou Province, China, gzu.edu.cn.
  • Department of Cardiology, Guizhou Provincial Key Laboratory of Pathogenesis and Prevention of Common Chronic Diseases, Guiyang City, Guizhou Province, China.
  • Department of Cardiology, The Second Affiliated Hospital of Zunyi Medical University, Zunyi City, Guizhou Province, China, zmc.edu.cn.
  • Department of Pharmacy, The First Affiliated Hospital of Guangxi Medical University, Nanning City, Guangxi Province, China, gxmu.edu.cn.

ORCID-Profile: Youfu He, Yu Qian, Zhiwei Zheng, Yu Zhou, Chen Li, Qiang Wu

Förderung

  • Science and Technology Program of Guizhou Province
  • Health Commission of Guizhou Province

Zitieren

APA

He, Y., Qian, Y., Zheng, Z., Zhou, Y., Li, C., Wu, Q., & Ren, M. (2026). Exosomal lncRNA FENDRR Orchestrates Immune Remodelling and Ferroptosis in the Comorbidity of Lung Cancer and Type 1 Myocardial Infarction. Human Mutation. https://doi.org/10.1155/humu/8861747

Vancouver

He Y, Qian Y, Zheng Z, Zhou Y, Li C, Wu Q, et al. Exosomal lncRNA FENDRR Orchestrates Immune Remodelling and Ferroptosis in the Comorbidity of Lung Cancer and Type 1 Myocardial Infarction. Human Mutation. 2026. doi:10.1155/humu/8861747

BibTeX
@article{He2026,
  author = {He, Youfu and Qian, Yu and Zheng, Zhiwei and Zhou, Yu and Li, Chen and Wu, Qiang and Ren, Minghua},
  title = {Exosomal lncRNA FENDRR Orchestrates Immune Remodelling and Ferroptosis in the Comorbidity of Lung Cancer and Type 1 Myocardial Infarction},
  journal = {Human Mutation},
  year = {2026},
  doi = {10.1155/humu/8861747}
}
Kostenlos starten →